Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Ordenar por: RelevânciaAutorTítuloAnoImprime registros no formato resumido
Registros recuperados: 3
Primeira ... 1 ... Última
Imagem não selecionada

Imprime registro no formato completo
Evaluation of lettuce chloroplast and soybean cotyledon as platforms for production of functional bone morphogenetic protein 2. Repositório Alice
QUEIROZ, L. N.; MALDANER, F. R.; MENDES, E. A.; SOUSA, A. R.; D?ALLASTTA, R. C.; MENDONÇA, G.; MENDONÇA, D. B. S.; ARAGÃO, F. J. L..
bitstream/item/195705/1/Queiroz2019-Article-EvaluationOfLettuceChloroplast.pdf
Tipo: Artigo em periódico indexado (ALICE) Palavras-chave: Biopharming; BMP2; Lettuce chloroplast; Soybean seeds; Transplastomic plant; Transgenic plants.
Ano: 2019 URL: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1108126
Imagem não selecionada

Imprime registro no formato completo
Pharmaceutical and Industrial Traits in Genetically Modified Crops: Co-existence with Conventional Agriculture AgEcon
Moschini, GianCarlo.
This paper discusses the implications of using genetically modified crops to biomanufacture pharmaceuticals and industrial compounds from the perspective of their co-existence with conventional agriculture. Such plant-made pharmaceuticals and plant-made industrial products rely on exciting scientific and technological breakthroughs and promise new opportunities for the agricultural sector, but they also entail novel risks. The management of the externalities and of the possible unintended economic effects that arise in this context is critical and poses difficult questions for regulators.
Tipo: Working or Discussion Paper Palavras-chave: Agriculture; Biopharming; Co-existence; Externalities; Genetically modified products; Liability; Molecular farming; Regulation; Crop Production/Industries; Research and Development/Tech Change/Emerging Technologies.
Ano: 2006 URL: http://purl.umn.edu/18544
Imagem não selecionada

Imprime registro no formato completo
Valuing Intellectual Property Rights in an Imperfectly Competitive Market: A Biopharming Application AgEcon
Kostandini, Genti; Mills, Bradford F..
Small research firms developing biotechnology applications often focus on establishing intellectual property rights (IPRs), which can then be sold to more established firms with existing market channels. This paper presents a method for valuing the IPRs for an innovation that lowers product production costs below those associated with the patented process of a monopolist. The application to Glucocerebrosidase enzyme from transgenic tobacco suggests an IPRs value of about $1.75 billion. Despite the innovator’s market power, significant surplus gains also accrue to consumers. Further, U.S. antitrust laws that prohibit IPRs acquisition by the current monopolist increase consumer welfare by almost 50%.
Tipo: Journal Article Palavras-chave: Biopharmaceuticals; Biopharming; Economic surplus; Imperfect competition; Intellectual property rights; Agribusiness; Demand and Price Analysis; Financial Economics; Marketing; D23; M13; D43; D60.
Ano: 2009 URL: http://purl.umn.edu/56641
Registros recuperados: 3
Primeira ... 1 ... Última
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional